Therapy of antigen-induced arthritis of the temporomandibular joint via platelet-rich plasma injections in domestic pigs

J Craniomaxillofac Surg. 2021 Aug;49(8):726-731. doi: 10.1016/j.jcms.2021.02.022. Epub 2021 Feb 26.

Abstract

The aim of this animal study was to investigate the effect of platelet-rich plasma (PRP) injections into the temporomandibular joint (TMJ) to treat antigen-induced arthritis AIA. AIA was induced via the application of bovine serum albumin (BSA) into the TMJ. Clear histological signs and protein analysis results indicating inflammation of the TMJ were observed. Afterwards, two PRP injections were performed over an interval of 2 weeks. Concentration levels of the proinflammatory cytokines IL-1β (PRP: 33.7 ± 5.6 pg/mg, untreated: 50.0 ± 2.9 pg/mg; p = 0.04) and TNF-α (PRP: 20.7 ± 2.5 pg/mg, untreated: 31.4 ± 2.7 pg/mg; p = 0.03) were significantly decreased in the PRP-treated joints. A significant reduction in signs of histological inflammation, such as hyperplasia of the synovial membrane, leucocyte infiltration, cartilage surface alterations, and an increase in cartilage-specific glycosaminoglycan content, was observed. This animal study supports the understanding of the underlying effects of PRP treatment in the TMJ, and may enhance novel PRP therapies in the future.

Keywords: Large-animal model; Platelet-rich plasma; Rheumatoid arthritis; Temporomandibular joint.

MeSH terms

  • Animals
  • Arthritis*
  • Cartilage, Articular*
  • Injections, Intra-Articular
  • Platelet-Rich Plasma*
  • Sus scrofa
  • Swine
  • Temporomandibular Joint